Comparative efficacy of zanubrutinib (ZANU) versus fixed-duration acalabrutinib plus venetoclax (AV) for first-line treatment of chronic lymphocytic leukemia (CLL): A matching-adjusted indirect comparison (MAIC)
No Thumbnail Available
All Authors
Munir,Tahla
Yang,Keri
Xu,Sheng
Williams,Rhys
Shadman,Mazyar
LTHT Author
Munir, Talha
LTHT Department
Oncology
Haematology
Haematology
Non Medic
Publication Date
2025
Item Type
Article
Language
Subject
Subject Headings
Abstract
Journal
Journal of Clinical Oncology